MediciNova, Inc. (MNOV) Earnings History
Annual and quarterly earnings data from 2003 to 2025
Loading earnings history...
MNOV EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
MNOV Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 7.6% | -3242.5% | -2928.8% |
| 2024 | - | - | - |
| 2023 | 100.0% | -990.0% | -857.2% |
| 2022 | - | - | - |
| 2021 | 100.0% | -253.0% | -251.0% |
Download Data
Export MNOV earnings history in CSV or JSON format
Free sign-in required to download data
MediciNova, Inc. (MNOV) Earnings Overview
As of May 8, 2026, MediciNova, Inc. (MNOV) reported trailing twelve-month net income of -$12M, reflecting -4.3% year-over-year growth. The company earned $-0.24 per diluted share over the past four quarters, with a net profit margin of -2928.8%.
Looking at the long-term picture, MNOV's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2013.
MediciNova, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SIGA (-$4.04T net income, 24.6% margin), NRXP (-$38M net income, -2336.5% margin), AVXL (-$40M net income), MNOV has room to improve margins relative to the peer group. Compare MNOV vs SIGA →
MNOV Earnings vs Peers
Earnings metrics vs comparable public companies
MNOV Historical Earnings Data (2003–2025)
23 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$12M | -8.6% | -$13M | $-0.24 | -2928.8% | -3242.5% |
| 2024 | -$11M | -28.9% | -$13M | $-0.23 | - | - |
| 2023 | -$9M | +39.1% | -$10M | $-0.17 | -857.2% | -990.0% |
| 2022 | -$14M | -38.8% | -$15M | $-0.29 | - | - |
| 2021 | -$10M | +26.8% | -$10M | $-0.21 | -251.0% | -253.0% |
| 2020 | -$14M | -7.0% | -$14M | $-0.31 | - | - |
| 2019 | -$13M | +11.8% | -$14M | $-0.30 | - | - |
| 2018 | -$15M | -31.5% | -$16M | $-0.36 | - | - |
| 2017 | -$11M | -2.7% | -$13M | $-0.32 | - | - |
| 2016 | -$11M | -22.8% | -$11M | $-0.33 | - | - |
See MNOV's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MNOV Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MNOV vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMNOV — Frequently Asked Questions
Quick answers to the most common questions about buying MNOV stock.
Is MNOV growing earnings?
MNOV EPS of $-0.24 reflects slowing growth at -4.3%, below the 5-year CAGR of N/A. TTM net income is $-12M. Expansion rate has moderated.
What are MNOV's profit margins?
MediciNova, Inc. net margin is -2928.8%, with operating margin at -3242.5%. Below-average margins reflect competitive or cost pressures.
How consistent are MNOV's earnings?
MNOV earnings data spans 2003-2025. The current earnings trend is -4.3% YoY. Historical data enables comparison across business cycles.